GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like Novartis AG Lays Out R&D Game Plan at Meet and Greet With 30 Execs in Boston May 31, 2017 Celgene Crashed After Follicular Lymphoma Regimen Failed Phase III December 21, 2017 GE Healthcare to Shutter Maryland Plant, Nearly 200 Employees Affected February 6, 2017
